Botulinum toxin A therapy for medial rectus injury during endoscopic sinus surgery

Am J Rhinol. 2008 Jan-Feb;22(1):95-7. doi: 10.2500/ajr.2008.22.3123.

Abstract

Background: Although the use of endoscopes and image guidance provide some safeguards, motility complications from orbital injury during endoscopic sinus surgery still pose a significant concern and can provide a therapeutic challenge.

Methods: We present the case of a 40-year-old woman with strabismus secondary to an iatrogenic injury to the medial rectus muscle during endoscopic sinus surgery.

Results: Permanent resolution of diplopia was achieved with botulinum toxin A injection into the lateral rectus muscle without the need for surgical intervention.

Conclusion: Botulinum toxin A should be considered as a first-line early therapeutic option for cases of iatrogenically induced strabismus after endoscopic sinus surgery when complete transection or entrapment is not present.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / administration & dosage*
  • Diplopia / drug therapy*
  • Diplopia / etiology
  • Diplopia / physiopathology
  • Endoscopy / adverse effects*
  • Eye Movements
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intramuscular
  • Magnetic Resonance Imaging
  • Neuromuscular Agents / administration & dosage*
  • Oculomotor Muscles / injuries*
  • Otorhinolaryngologic Surgical Procedures / adverse effects*
  • Otorhinolaryngologic Surgical Procedures / methods
  • Sinusitis / diagnosis
  • Sinusitis / surgery*
  • Tomography, X-Ray Computed

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A